Pressure BioSciences Inc.: Pressure BioSciences, Inc. Reports Q1 2022 Financial Results
Focused on the Successful Launch of its "Early Access Program" for the UST Platform, Company Already Negotiating with Four Potential Customers for Nanoemulsion Processing in Nutraceuticals and CosmeticsInvestor
Source: finanznachrichten.de